Next-generation platform
Colin Kerr
Published: Thursday, March 1, 2018
Bausch + Lomb, has received CE Mark from the European Commission for the Stellaris Elite Vision Enhancement System, the company’s ophthalmic surgical platform.
“We’re pleased to bring the Stellaris Elite Vision Enhancement System, including the cutting-edge Vitesse technology, to the greater European market,” said Joseph C. Papa, chairman and
CEO, Valeant.
“Because this surgical platform offers the opportunity to continuously add innovative upgrades and enhancements, it enables surgeons to customise their systems and expand their capabilities as their needs evolve,” he said.
www.bausch.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.